St Jude builds up AF division with IBI (Irvine Biomedical) purchase
This article was originally published in Clinica
St Jude Medical is to acquire the remaining shares of Irvine Biomedical (IBI), a privately-held developer of electrophysiology (EP) catheter products in which St Jude already has a 14% ownership.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.